% | $
Quotes you view appear here for quick access.

công ty Questcor Pharmaceuticals Message Board

  • chipin8511 chipin8511 May 1, 2013 9:33 AM Flag

    Upgrade roflo

    After Questcor reported weaker than expected Q1 results, Roth Capital thinks the revenue miss was caused by temporary factors. The firm notes that Questcor said its sales momentum had improved in recent weeks, and Roth reiterates a $47 price target and Buy rating on the shares.

93.60+1.52(+1.65%)Aug 14 4:00 PMEDT